Innovative therapeutics

sidebar_clinical_trials_drisapersen

Duchenne Muscular Dystrophy (drisapersen)

Download the Duschenne Clinical Trial pdf

Click here to open the full-size pdf.

Clinical Trial

A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
Read more »

Clinical Trial

Phase IIb Study of PRO045 in Subjects with Duchenne Muscular Dystrophy
Read more »

Clinical Trial

A Phase 1/2, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients with Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration
Read more »

Clinical Trial

Open Label, Extension Study of PRO 044 in Duchenne Muscular Dystrophy (DMD)
Read more »

Clinical Trial

A Phase 1/2 Study of PRO053 in Subjects with Duchenne Muscular Dystrophy (DMD)
Read more »

Clinical Trial

An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
Read more »

Clinical Trial

A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD114044)
Read more »

Clinical Trial

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects with Duchenne Muscular Dystrophy (DMD) (DMD114876)
Read more »

Clinical Trial

Phase I/II Study of PRO 044 in Duchenne Muscular Dystrophy (DMD)
Read more »

Top